Dizal Pharmaceutical Co Ltd
SSE:688192
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dizal Pharmaceutical Co Ltd
SSE:688192
|
CN |
|
G
|
Genuine Parts Co
F:GPT
|
US |
|
HB Fuller Co
NYSE:FUL
|
US |
|
M
|
Murray & Roberts Holdings Ltd
SWB:LDYA
|
ZA |
|
X4 Pharmaceuticals Inc
NASDAQ:XFOR
|
US |
|
Norditek Group AB
STO:NOTEK
|
SE |
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
DK |
|
H
|
HLB Pep Co Ltd
KOSDAQ:196300
|
KR |
|
O
|
O'Reilly Automotive Inc
LSE:0KAB
|
US |
|
C
|
Carasent AB (publ)
STO:CARA
|
SE |
|
T
|
TotalEnergies SE
XHAM:TOTB
|
FR |
|
T
|
Tencent Holdings Ltd
DUS:NNN1
|
CN |
|
Agora Inc
NASDAQ:API
|
US |
|
Allan International Holdings Ltd
HKEX:684
|
HK |
|
D
|
DFI Retail Group Holdings Ltd
LSE:DFI
|
HK |
|
Lamar Advertising Co
NASDAQ:LAMR
|
US |
|
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
|
US |
|
Live World Inc
OTC:LVWD
|
US |
|
T
|
Thinkon Semiconductor Jinzhou Corp
SSE:688233
|
CN |
|
G
|
GoDaddy Inc
SWB:38D
|
US |
|
E
|
ENM Holdings Ltd
HKEX:128
|
HK |
|
Turk Hava Yollari AO
IST:THYAO.E
|
TR |
|
U
|
UniCredit SpA
XHAM:CRIN
|
IT |
|
Sichuan Em Technology Co Ltd
SSE:601208
|
CN |
Bankruptcy Probability
Dizal Pharmaceutical Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Dizal Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
D
|
Dizal Pharmaceutical Co Ltd
SSE:688192
|
31.4B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
509.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
208B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
137.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
96.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
96.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
52.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
38.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Dizal Pharmaceutical Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Dizal Pharmaceutical Co Ltd has total debt of 973.5m CNY. This includes both short-term (48.9m CNY) and long-term (924.6m CNY) debt.
You can find a full breakdown on its Balance Sheet.